We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+19.35%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$7.73B
AUM Growth
+$2.12B
Cap. Flow
+$1.68B
Cap. Flow %
21.74%
Top 10 Hldgs %
62.44%
Holding
254
New
94
Increased
43
Reduced
43
Closed
35

Sector Composition

Rank Sector Weight
1 Financials 5.26%
2 Healthcare 4.58%
3 Industrials 4.51%
4 Utilities 3.83%
5 Consumer Discretionary 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSY icon
201
Bentley Systems
BSY
$10.6B
$314K ﹤0.01%
+10,000
New +$323K
ROAD icon
202
Construction Partners
ROAD
$6.77B
$308K ﹤0.01%
16,900
-33,100
-66% -$593K
CHWY icon
203
Chewy
CHWY
$9.63B
$274K ﹤0.01%
+5,000
New +$270K
LYRA
204
DELISTED
LYRA THERAPEUTICS INC
LYRA
$266K ﹤0.01%
476
RPTX
205
DELISTED
Repare Therapeutics
RPTX
$262K ﹤0.01%
8,500
-5,000
-37% -$132K
CSTL icon
206
Castle Biosciences
CSTL
$979M
$257K ﹤0.01%
5,000
-2,500
-33% -$111K
VSTA
207
DELISTED
Vasta Platform
VSTA
$231K ﹤0.01%
+15,000
New +$248K
BCYC
208
Bicycle Therapeutics
BCYC
$292M
$229K ﹤0.01%
12,000
-500
-4% -$8.83K
TBIO
209
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$204K ﹤0.01%
15,000
+5,000
+50% +$77.1K
ORIC icon
210
Oric Pharmaceuticals
ORIC
$1.4B
$200K ﹤0.01%
8,000
SPCE icon
211
Virgin Galactic
SPCE
$398M
$192K ﹤0.01%
+500
New +$190K
CNTG
212
DELISTED
Centogene N.V. Common Shares
CNTG
$189K ﹤0.01%
+20,000
New +$255K
VIAO
213
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$133K ﹤0.01%
+14,900
New +$144K
EVFM
214
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$118K ﹤0.01%
3,333
-3,334
-50% -$145K
CHX
215
DELISTED
ChampionX
CHX
$80K ﹤0.01%
10,000
-12,103
-55% -$117K
DGNR.U
216
DELISTED
Dragoneer Growth Opportunities Corp. Units, each consisting of one Class A ordinary share, and one-f
DGNR.U
$12K ﹤0.01%
+1,000
New +$11.9K
APTV icon
217
Aptiv
APTV
$10.3B
-25,000
Closed -$1.95M
BA icon
218
PUT
Boeing
BA
$185B
-15,000
Closed -$2.75M
BSX icon
219
Boston Scientific
BSX
$71.5B
-13,000
Closed -$456K
CRWD icon
220
PUT
CrowdStrike
CRWD
$218B
-40,000
Closed -$1M
ES icon
221
Eversource Energy
ES
$27.2B
-5,000
Closed -$416K
ESNT icon
222
Essent Group
ESNT
$6.33B
-10,300
Closed -$374K
GBIO
223
DELISTED
Generation Bio
GBIO
-1,200
Closed -$252K
ICVT icon
224
PUT
iShares Convertible Bond ETF
ICVT
$7.46B
-150,000
Closed -$3.86M
IDYA icon
225
IDEAYA Biosciences
IDYA
$3.56B
-5,000
Closed -$71K

Similar funds

Pentwater Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Pentwater Capital Management held 254 positions worth $7.73B, up 38% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Pentwater Capital Management deployed $1.68B of net new capital in Q3 2020, opening 94 new positions and adding to 43 existing holdings. Its largest new stake was Maxim Integrated Products: 7,093,000 shares worth $480M.

By sector, the portfolio is most concentrated in Financials at 5.3% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was TD Ameritrade Holding Corp, an estimated $47.6M trimmed.

  • Pentwater Capital Management's largest Q3 2020 buy was Maxim Integrated Products: 7,093,000 shares worth $480M.
  • Pentwater Capital Management added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q3 2020, an estimated $156M increase.
  • Pentwater Capital Management's biggest Q3 2020 reduction was TD Ameritrade Holding Corp, cutting an estimated $47.6M.
  • Pentwater Capital Management fully exited 58.com Inc in Q3 2020, selling an estimated $267M.
  • Pentwater Capital Management's ten largest holdings make up 62% of its $7.73B portfolio in Q3 2020.
  • Pentwater Capital Management opened 94 new positions and closed 35 in Q3 2020.
  • Pentwater Capital Management's portfolio value rose 38% quarter-over-quarter to $7.73B.

Based on Pentwater Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.